Topical endoxifen
ATOS-010
Phase 2 small_molecule completed
Quick answer
Topical endoxifen for Mammographic Breast Density is a Phase 2 program (small_molecule) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ATOSSA THERAPEUTICS, INC.
- Indication
- Mammographic Breast Density
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed